$AMRZ

Amrize AG Non-GAAP EPS of $1.05 in-line, revenue of $3.77B misses by $60M (AMRZ:NYSE)

Amrize AG reported Q3 Non-GAAP EPS of $1.05, meeting estimates, while revenue of $3.77B missed expectations by $60M, up 2.7% year-over-year. The company's outlook and market position are under discussion.

Original reporting
Published Oct 28, 2026, 8:53 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 28, 2026, 8:56 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$AMRZ
Bearish
high confidence
Mentioned
$AMRZ
Relevance
7/10
AlphAI data visualization · based on seekingalpha.com
Decision brief

The 30-second read

$AMRZBearishMed
01

Why it matters

The earnings release provides fresh data that may influence short-term trading decisions.

02

Market read

Earnings data introduces new information for traders; modest impact expected.

03

What to watch

Potential cost reductions and upcoming margin improvements could offset short-term revenue weakness.

Relevance 7/10Novelty 8/10Timing: post-market today

Background

Amrize AG released its Q3 2026 earnings, highlighting in-line EPS and a slight revenue miss.

Company-level read

Ticker impact

$AMRZBearishHigh confidence
Context

Q3 2026 Non-GAAP EPS of $1.05 in-line; revenue $3.77B missed expectations by $60M.

Expected impact

likely modest downside as market prices in the revenue shortfall

Evidence & confidence

Investors typically react negatively to revenue misses even when EPS meets expectations.

Market effects

Building materials sector may see slight pressure if Amrize's miss signals broader demand concerns.

US-listed material stocks could experience modest pullback.

Limited to investors tracking mid-cap industrials.

Counterpoint

Revenue miss may be temporary; focus on margin recovery outlook for 2027.

Key entities

  • Amrize AG

    Building materials firm listed on NYSE under ticker AMRZ.

Related articles

Med

Amrize Reports Third Quarter 2026 Results

Amrize Ltd (AMRZ) filed an SEC Form 8-K — Results of Operations and Financial Condition. Amrize Reports Third Quarter 2026 Results • Revenues up 2.2% to $3,771 million • Net Income grew 3.3% to $558 million • Adjusted EBITDA increased 0.2% to $1,076 million • Margin expansion of 30 basis points in Building Materials • Completed Rapid Redi-Mix acquisition in Dallas-Fo

Med

A $1 billion share-buyback program is complete; Amrize returned $1.1 billion to shareholders

Amrize completed a $1 billion share-buyback program, returning $1.1 billion to shareholders. Q3 2026 revenue rose 2.2% to $3.77 billion, net income increased 3.3% to $558 million, and adjusted EBITDA grew 0.2% to $1.076 billion. The company updated FY 2026 guidance, citing cost inflation and higher interest rates. Amrize also declared a $0.11 per share dividend and completed the Rapid Redi-Mix acquisition in Dallas-Fort Worth.